Cross Country Healthcare agrees $437 million acquisition by Knox Lane

10 articles · Updated · MarketWatch · May 6

The all-cash deal values the healthcare workforce solutions company at $13.25 per share, the companies said on Wednesday.
After closing, expected in the third quarter, Cross Country will become privately held, remain under its current name and brand, and stop trading on Nasdaq.
The transaction still requires shareholder and regulatory approval, while Knox Lane said it plans to add strategic focus and capabilities to the business.

As private equity cashes in on the nursing shortage, what does this $437M deal mean for the future of patient care?

Can a profit-driven owner truly solve the healthcare staffing crisis, or will it make a broken system even worse?